CHEST 2023 On Demand Pass-Update in Non-Respiratory Sleep Medicine: A Case-Based Approach

Video Transcription

Video Summary

In this video presented by a panel of sleep medicine experts, updates in non-respiratory sleep medicine are discussed. The session covers four important topics: restless leg syndrome (RLS), insomnia, hypersomnia, and narcolepsy, with a focus on pediatric sleep medicine. The panelists discuss the diagnosis, treatment, and recent advancements in each area. Restless leg syndrome is primarily treated with alpha-2-delta calcium channel ligands, such as gabapentin, pregabalin, or gabapentin-inicarbin. Dopamine agonists, which were previously the first choice, are now the second choice due to side effects. For insomnia, cognitive-behavioral therapy for insomnia (CBTI) is recommended as the first-line treatment, with medications being used on a case-by-case basis. Hypersomnia, including narcolepsy and idiopathic hypersomnia, can have comorbidities such as obesity, mood disorders, and movement disorders, and may be treated with medications such as stimulants and histamine agonists. An update in pediatric sleep medicine includes the recognition of restless sleep disorder as its own entity, with specific diagnostic criteria. Treatment options for restless sleep disorder include iron supplementation, both oral and intravenous, with a focus on increasing ferritin levels. The panel emphasizes the importance of accurate diagnosis and tailored treatment plans for patients with sleep disorders.

Meta Tag

Category Sleep Disorders

Session ID 1012

Speaker Diwakar Balachandran

Speaker Caroline Okorie

Speaker Lilit Sargsyan

Speaker Saiprakash Venkateshiah

Track Sleep Disorders

Keywords

sleep medicine

non-respiratory sleep medicine

restless leg syndrome

insomnia

hypersomnia

narcolepsy

pediatric sleep medicine

diagnosis

treatment